Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data

Coronary artery disease (CAD) remains one of the most important causes of morbidity and mortality worldwide, and revascularization through percutaneous coronary interventions (PCI) significantly improves survival. In this setting, poor glycaemic control, regardless of diabetes, has been associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nusca, Annunziata, Piccirillo, Francesco, Bernardini, Federico, De Filippis, Aurelio, Coletti, Federica, Mangiacapra, Fabio, Ricottini, Elisabetta, Melfi, Rosetta, Gallo, Paolo, Cammalleri, Valeria, Napoli, Nicola, Ussia, Gian Paolo, Grigioni, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266811/
https://www.ncbi.nlm.nih.gov/pubmed/35806265
http://dx.doi.org/10.3390/ijms23137261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266811/
https://www.ncbi.nlm.nih.gov/pubmed/35806265
http://dx.doi.org/10.3390/ijms23137261

Ejemplares similares